115 related articles for article (PubMed ID: 19897610)
1. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.
Barabutis N; Siejka A; Schally AV; Block NL; Cai R; Varga JL
J Mol Endocrinol; 2010 Feb; 44(2):127-34. PubMed ID: 19897610
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.
Barabutis N; Tsellou E; Schally AV; Kouloheri S; Kalofoutis A; Kiaris H
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5575-9. PubMed ID: 17372203
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
[TBL] [Abstract][Full Text] [Related]
5. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.
Kiaris H; Schally AV; Busto R; Halmos G; Artavanis-Tsakonas S; Varga JL
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):196-200. PubMed ID: 11773624
[TBL] [Abstract][Full Text] [Related]
6. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.
Chatzistamou I; Volakaki AA; Schally AV; Kiaris H; Kittas C
Regul Pept; 2008 Apr; 147(1-3):33-6. PubMed ID: 18255167
[TBL] [Abstract][Full Text] [Related]
7. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.
Christodoulou C; Schally AV; Chatzistamou I; Kondi-Pafiti A; Lamnissou K; Kouloheri S; Kalofoutis A; Kiaris H
Regul Pept; 2006 Sep; 136(1-3):105-8. PubMed ID: 16781787
[TBL] [Abstract][Full Text] [Related]
8. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the pituitary somatotroph cell by GHRH and its receptor.
Mayo KE; Miller T; DeAlmeida V; Godfrey P; Zheng J; Cunha SR
Recent Prog Horm Res; 2000; 55():237-66; discussion 266-7. PubMed ID: 11036940
[TBL] [Abstract][Full Text] [Related]
11. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.
Kiaris H; Chatzistamou I; Schally AV; Halmos G; Varga JL; Koutselini H; Kalofoutis A
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9512-7. PubMed ID: 12867592
[TBL] [Abstract][Full Text] [Related]
13. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.
Havt A; Schally AV; Halmos G; Varga JL; Toller GL; Horvath JE; Szepeshazi K; Köster F; Kovitz K; Groot K; Zarandi M; Kanashiro CA
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17424-9. PubMed ID: 16299104
[TBL] [Abstract][Full Text] [Related]
14. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
15. A correlation of endocrine and anticancer effects of some antagonists of GHRH.
Kovács M; Schally AV; Hohla F; Rick FG; Pozsgai E; Szalontay L; Varga JL; Zarándi M
Peptides; 2010 Oct; 31(10):1839-46. PubMed ID: 20633588
[TBL] [Abstract][Full Text] [Related]
16. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
[TBL] [Abstract][Full Text] [Related]
17. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target.
Xiong X; Ke X; Wang L; Yao Z; Guo Y; Zhang X; Chen Y; Pang CP; Schally AV; Zhang H
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6726-6732. PubMed ID: 32156725
[TBL] [Abstract][Full Text] [Related]
18. Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2.
Catanuto P; Tashiro J; Rick FG; Sanchez P; Solorzano CC; Glassberg MK; Block NL; Lew JI; Elliot SJ; Schally AV
Horm Cancer; 2015 Jun; 6(2-3):100-6. PubMed ID: 25752763
[TBL] [Abstract][Full Text] [Related]
19. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.
Chatzistamou I; Schally AV; Kiaris H; Politi E; Varga J; Kanellis G; Kalofoutis A; Pafiti A; Koutselini H
Eur J Endocrinol; 2004 Sep; 151(3):391-6. PubMed ID: 15362970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]